Meeting details menu

Meeting Authors
Meeting Abstracts
Keynote lectures
Oral communications
Poster presentations
Special symposia
Other

Acta Physiologica Congress

Back

Acta Physiologica 2007; Volume 189, Supplement 653
The 86th Annual Meeting of The German Physiological Society
3/25/2007-3/28/2007
Hannover, Germany


DISCRIMINATION BETWEEN INTEGRIN- AND GLYCOCALIX- MEDIATED ADHESION AND MIGRATION OF HUMAN MELANOMA CELLS
Abstract number: P15-L4-13

Krahling1 H, Mally1 S, Schwab1 A, Stock1 C

1Institute of Physiology II, University of Mnster

The present study focuses on the question to what extent adhesion and migration of human melanoma cells (MV3) are mediated by integrins or components of the glycocalix. Earlier experiments showed that melanoma cells still adhered to a collagen matrix even when the a2b1 integrin mediated part of cell adhesion was blocked by the snake-venom rhodocetin. To identify the contribution of the glycocalix to cell adhesion and migration, human melanoma cells were seeded on collagen matrices and treated with tunicamycin for different time periods. Tunicamycin prevents the formation of n-acetyl-glucosamine lipid intermediates and glycosylation of newly synthesized proteins by inhibiting N-acetylglucosamin transferases. Tunicamycin led to a decrease of the migratory speed by 25% and a reduction of the number of cells adhesive to the collagen matrix by 20%. We quantified the tunicamycin-dependent loss of the glycocalix by staining the cells with fluorescently labeled wheat germ agglutinine (WGA). Tunicamycin treated cells showed a reduction of fluorescence intensity by 20%. Results imply a basic importance of the glycocalix for cell migration of human melanoma cells.

To cite this abstract, please use the following information:
Acta Physiologica 2007; Volume 189, Supplement 653 :P15-L4-13

Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.

By continuing to browse this site you agree to us using cookies as described in our standard cookie policy .

CLOSE